AMSBIO signs strategic advertising agreement with Luxcel Biosciences AMSBIO offers signed a strategic advertising agreement with Luxcel Biosciences to distribute their selection of 96 – and 384-good phosphorescence and fluorescence based assays. The easy to use assays measure oxygen usage of isolated mitochondria, cell populations, small organisms, enzymes and tissues. The assay detects changes in extracellular pH due to the acid extrusion of either adherent or suspension cells. This enables convenient plate based analysis of glycolytic flux and may be utilized to monitor alterations in glucose metabolism also to confirm mitochondrial dysfunction. Alex Sim, President of AMSBIO commented We are pleased to add the Luxcelrange to your product portfolio as they compliment our innovative 3D cell culture items and extensive suite of cell centered assays for proliferation, invasion and migration.Related StoriesInnovative single-use torque instruments utilize difficult polycarbonate from BayerWHO committed to helping Nepal deliver health care to its citizens, says WHO South-East Asia Regional DirectorInnovative IV pole making use of polycarbonate resin mix from Bayer enhances patient and health care worker safety The findings suggest that of adult individuals who have undergone a tonsillectomy, 20 % got a complication, ten % visited a crisis room, and approximately 1.5 % were admitted to a hospital within 2 weeks of the task.